is wegovy semaglutide or tirzepatide vs Tirzepatide: Key Differences Learn more about GLP 1

Earlier SURMOUNT-1 data further reinforced these outcomes, with tirzepatide demonstrating weight loss of up to 22.5% of body weight over 72 weeks, the highest ever recorded for a pharmacological weight loss therapy at that time

2025;22((Suppl

You can use the same thigh weekly, but you must rotate the exact injection spot within that thigh

11 A study has shown that GLP-1Rs are increased in the visceral adipose tissue of morbidly obese patients with insulin resistance

For subcutaneous semaglutide, we suggest starting at the intermediary 0.5 mg once-weekly dose for 4 weeks before transitioning to the maximal therapeutic dose of 1 mg once weekly to help avoid adverse GI effects (Figure 2)